GERN Insider Trading
Insider Ownership Percentage: 3.10%
Insider Buying (Last 12 Months): $46,150.00
Insider Selling (Last 12 Months): $6,808,003.88
Geron Share Price & Price History
Current Price: $1.27
Price Change: ▲ Price Increase of +0.03 (2.42%)
As of 04/17/2025 05:00 PM ET
Geron Insider Trading History
Geron Institutional Trading History
Data available starting January 2016
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Read More on Geron
Volume
8,286,588 shs
Average Volume
11,448,970 shs
Market Capitalization
$808.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.66
Who are the company insiders with the largest holdings of Geron?
Geron's top insider shareholders include:
- John A Scarlett (CEO)
- Scott Alan Samuels (EVP)
- Elizabeth G O'farrell (Director)
- Andrew J Grethlein (COO)
- Faye Feller (EVP)
- Susan Molineaux (Director)
- V Bryan Lawlis (Director)
Learn More about top insider investors at Geron.
Who are the major institutional investors of Geron?
Which major investors are selling Geron stock?
Within the last quarter, GERN stock was sold by these institutional investors:
- Hennion & Walsh Asset Management Inc.
In the previous year, company insiders that have sold Geron company stock include:
- John A Scarlett (CEO)
- Scott Alan Samuels (EVP)
- Elizabeth G O'farrell (Director)
Learn More investors selling Geron stock.
Which major investors are buying Geron stock?
During the previous quarter, GERN stock was acquired by institutional investors including:
- Exchange Traded Concepts LLC
- Moody National Bank Trust Division
- Sowell Financial Services LLC
In the previous year, these company insiders have bought Geron stock:
- John A Scarlett (CEO)
- Scott Alan Samuels (EVP)
- Elizabeth G O'farrell (Director)
Learn More investors buying Geron stock.